SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Crawford James C
(Last) (First) (Middle)
C/O ASPIRA WOMEN'S HEALTH INC
12117 BEE CAVES RD, BLDG 3-100
(Street)
AUSTIN, TX 78738
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/28/2025 		3. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President of Finance
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) (1) 03/31/2032 Common Stock 400 $15.6 D
Employee Stock Option (Right to Buy) (2) 01/20/2033 Common Stock 1,000 $7.5 D
Employee Stock Option (Right to Buy) (3) 02/08/2033 Common Stock 666 $8.7 D
Employee Stock Option (Right to Buy) 02/08/2023 02/08/2033 Common Stock 333 $8.7 D
Employee Stock Option (Right to Buy) (4) 02/14/2034 Common Stock 1,600 $4.87 D
Employee Stock Option (Right to Buy) (5) 07/03/2034 Common Stock 3,500 $0.94 D
Employee Stock Option (Right to Buy) (6) 08/08/2034 Common Stock 25,000 $1.17 D
Employee Stock Option (Right to Buy) 11/21/2024 11/21/2034 Common Stock 1,000 $0.75 D
Employee Stock Option (Right to Buy) (7) 06/24/2031 Common Stock 800 $88.5 D
Explanation of Responses:
1. The option vests in four equal annual installments beginning on March 31, 2023.
2. The option vests in four equal annual installments beginning on January 20, 2024.
3. The option vests in three equal annual installments beginning on February 8, 2024.
4. The option vests in three equal annual installments beginning on February 14, 2025.
5. The option vests 100% on July 3, 2025.
6. The option vests in 48 equal monthly installments beginning on September 8, 2024.
7. The option vests in four equal annual installments beginning on May 24, 2022.
/s/ James Crawford 03/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.